Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026
Viatris (Nasdaq: VTRS) will report fourth quarter and full year 2025 financial results on February 26, 2026 and will host a live webcast at 8:30 a.m. ET the same day.
Rhea-AI Summary
Viatris (Nasdaq: VTRS) will report fourth quarter and full year 2025 financial results on February 26, 2026 and will host a live webcast at 8:30 a.m. ET the same day. A replay will be available on the investor website.
Viatris also will host an Investor Event in New York City on March 19, 2026; additional details and pre-registration information will be provided during the February 26 investor call.
Positive
- None.
Negative
- None.
Details
News Market Reaction – VTRS
On Feb 4, the first trading day after this news, VTRS closed 4.97% above the previous close.
Data tracked by StockTitan Argus for the Feb 4 session.
Key Figures
- Earnings date
- February 26, 2026
- Q4 and full year 2025 financial results release
- Earnings call time
- 8:30 a.m. ET
- Webcast to discuss Q4 and full year 2025 results
- Investor event date
- March 19, 2026
- Planned Viatris Investor Event in New York City
- US dial-in number
- 844.308.3344
- Domestic access number for the earnings webcast call
- International dial-in
- 412.317.1896
- International access number for the earnings webcast call
Historical Context
-
Launch of data-driven Resilience Quotient risk and resilience analytics platform.
-
Appointment of new Chief People and Corporate Affairs Officer to align people and affairs.
-
Multiple FDA and PMDA regulatory milestones across generics, women’s health, and gene therapy.
-
Participation in J.P. Morgan Healthcare Conference with webcasted presentation and fireside chat.
-
Planned participation in two December healthcare investor conferences with webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
In addition, Viatris will host an Investor Event on March 19, 2026, in
Analysts and institutional investors will be invited to pre-register for the event and attend through an invite that will be distributed separately. Interested parties will also be able to access a live webcast of the event at investor.viatris.com. A replay of the webcast also will be available on the website.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026-and-host-investor-event-on-march-19-2026-302678203.html
SOURCE Viatris Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.